Background/objectives: Meaningful profiling of pancreatic cancer samples is particularly challenging due to their complex cellular composition. Beyond tumor cells, surgical biopsies contain desmoplastic stroma with infiltrating inflammatory cells, adjacent normal parenchyma, and "non-pancreatic tissues". The risk of misinterpretation rises when the heterogeneous cancer tissues are sub-divided into smaller fragments for multiple analytic procedures. Pre-analytic histological evaluation is the best option to characterize pancreatic tissue samples. Our aim was to develop a complement or alternative procedure to determine the cellular composition of pancreatic cancerous biopsies, basing on intra-analytic molecular annotation. A standard process for sample stratification at a molecular level does not yet exist. Particularly in the case of retrospective or data depository-based studies, when hematoxylin-eosin stained sections are not available, it supports the correct interpretation of expression profiles. Methods: A five-gene transcriptional signature (RNACellStrat) was defined that allows cell type-specific stratification of pancreatic tissues. Testing biopsy material from biobanks with this procedure demonstrated high correspondence of molecular (qRT-PCR and microarray) and histologic (hematoxylin-eosin stain) evaluations. Results: Notably, about a quarter of randomly selected samples (tissue fragments) were exposed as inappropriate for subsequent clinico-pathological interpretation. Conclusions: Via immediate intra-analytical procedure, our RNA-based stratification RNACellStrat increases the accuracy and reliability of the conclusions drawn from diagnostic and prognostic molecular information.
Introduction
A major challenge in the differential analysis of pancreatic tissues (healthy vs. inflamed vs. malignant pancreas) is the highly heterogeneous tissue composition. Normal pancreatic tissue contains exocrine (80%) and endocrine cells, a distinct ductal system and discrete connective tissue carrying lymphoid and blood vessels as well as nerves [1] . In pancreatic ductal adenocarcinoma (PDAC), this architecture is markedly changed. A varying number of tumor cells become surrounded by desmoplastic stroma, generated by myofibroblastic stellate cells. It contains hypertrophic vessels and nerves, diverse immune cell infiltrates and necrotic areas [2e6] . Also, malignant pancreatic tumors very often infiltrate peripancreatic fat, lymph nodes, the biliary duct or the duodenum, and e when progressed e the gall bladder, stomach or colon, so that other tissue types may be included in tissue samples obtained from pancreatic cancer patients during collection of the biopsies.
Molecular studies require pre-analytic quantitative characterization of the cell types contained in a complex tumor. Usually, the tissue specimen is evaluated by a pathologist, followed by the diagnosis and visual annotation of the cellular composition based on routine H&E tissue staining. However, patient material, which is provided for non-diagnostically research purposes, is frequently cut into several small fragments and further processed in the form of consecutive sections with changing architecture. This increases the risk of having varying non-tumorous/non-pancreatic proportions in the respective cancer samples. Those samples have to be reevaluated before analysis. Also, in studies using stored tissue homogenates or RNA, the tissue stratification by H&E-staining and visual evaluation is not feasible. Furthermore, for analyses based on already existing RNA-profiles, such as publically available data depositories, it is frequently impossible to procure the cellular composition of the analyzed specimen and ensure accuracy of the diagnostic (i.e. overexpression of tumor-cell specific molecules) or prognostic assumptions.
Our aim was to develop a simple and reliable molecular strategy for a cellular annotation of pancreatic samples, allowing intraanalytic adjustment and generation of comparable sets of tissue samples. In a previous study [7] , we observed that the expression of the PNLIPRP2 gene correlated with the percentage of normal acinar parenchyma contained in the analyzed pancreata. This observation enabled an intra-analytical stratification of the samples and consequently a superior interpretation of the data, showing immunogenicity of the pancreatic molecules. These data allowed us to avoid overstatements in regard to PNLIPRP2 in a study dealing with epigenetic regulation in pancreatic cancer [8] , because emergence of PNLIPRP2 among top epigenetically-silenced pancreatic genes might rather reflect replacement of PNLIPRP2-positive acini (epithelium) with PNLIPRP2-negative stroma (mesenchyme), i.e. represent a lineage-specific but not tumorspecific phenomenon. This encouraged us to develop a stratification procedure by employing a multi-gene marker algorithm for cellular annotation of RNA-profiled data (RNACellStrat). Our approach enables a simple, intra-analytic classification of each particular specimen, beyond routine H&E staining, and consequently a reliable interpretation of the molecular data resulting from biomedical studies.
Material and methods

Patients and specimens
The study was performed with tissue samples obtained from patients admitted to the Department of General, Visceral [9] . Pancreatic biopsies were immediately snap-frozen in liquid nitrogen and stored at À80 C. Table 1 provides an overview of the patient cohorts used in the study.
Samples preparation
To achieve most accurate comparability of histological and molecular evaluations (H&E-stained tissues' images and RNA expression profiles, respectively), the frozen tissue samples were cut into 10 mm sections with a cryotom (LEICA Biosystems, Wetzlar, Germany). After 10 serial cuts, one tissue section was transferred to a glass slide and stained with H&E. Subsequently, a pathologist visually quantified the proportion of acinar, stromal fat, endocrine and immune compartments in the specimen. A percentage value was assigned to each compartment. The remaining sections were collected for RNA isolation and transcriptional profiling by qRT-PCR-or microarray-based technologies. Candidate annotation genes are given in Tables 1 and 2 .
Quantitative mRNA expression analyses by qRT-PCR
For qRT-PCR-based profiling, tissue sections have been processed to mRNA using MagNA Pure system (Roche Applied Science, Mannheim, Germany). Following cDNA synthesis, LightCycler ® -based real-time PCR was performed using the FastStart DNA SYBR Green kit and primers obtained from Search-LC (Heidelberg, Germany) as described previously [4, 5, 10] . The expression of each specific gene was normalized to housekeeping gene Cyclophilin B and presented as the number of transcripts per 10,000 copies of Cyclophilin B (10 kCPB).
Microarray RNA expression analysis
For microarray-based profiling, tissue sections have been processed to total RNA using AllPrep Isolation kit (Qiagen, Hilden, Germany). To synthesize first and second strand cDNA and for amplifying biotinylated cRNA, the Illumina Totalprep RNA Amplification Kit (Illumina) was used [11] . Genome-wide expression profiling was performed using Sentrix Human-6v3 Whole Genome Expression BeadChips (Illumina San Diego, CA, USA). Hybridization to the BeadChip microarrays was performed as recommended by the manufacturer: 10 ml cRNA was mixed with 20 ml GEX-HYB hybridization solution, heated, dispensed onto the large sample port of each array and incubated at 58 C for 18 h. Following hybridization, the samples were washed according to the standard protocol and scanned with a BeadArray Reader. Raw data was exported from the Beadstudio software to R [12] . The data was quantile normalized and log2 transformed. The threshold for background absorption was set to 4.0 and subtracted from all values. The potential cell-specific tissue marker probes are shown in Supplementary Table S1 . Clustering analyses and generation of the heat maps were performed using Chipster Software [13] . [14] .
Statistical analyses
Results
Definition of potential molecular marker genes for annotation of cellular composition in pancreatic biopsies
A literature search was performed to identify cell-type specific genes, which may be capable of representing the different compartments in pancreatic tumor samples. Under consideration were endocrine, acinar, ductal, tumor, stromal, fat, and immune
markers. Expression of b-cell-produced insulin (INS) marked
Langerhans islets -a major component of the endocrine compartment [15, 16] . The genes encoding enzymes produced by pancreatic acinar cells, amylase-A2-alpha (AMY2A) [17e19] and pancreatic lipase related protein 2 (PNLIPRP2) [20, 21] , were chosen as markers of normal exocrine parenchyma. Cytokeratin-19 (CK19) served as a marker for ductal epithelial cells, both normal and transformed [22, 23] . Differential overexpression of mesothelin (MSLN) was assumed to mark only malignant ductal epithelium [24, 25] . A desmoplastic reaction is characteristic of both inflammatory and cancerous pancreata. Generally, pancreatic stellate cells are activated in these tissues, with increased smooth muscle actin alpha (ACTA2/SMACTA2) expression as an indicator [2, 26, 27] . These cells produce excessive amounts of extracellular matrix proteins such as collagen type I (COL1A1) and fibronectin (FN1) [27, 28] . These three markers were therefore used for the identification of stellate cells and the extracellular matrix. Leptin (LEP) is secreted by adipocytes and serves as a marker for adipose tissue (fat) [29, 30] . To identify immune cell accumulation in tissue samples, diverse markers representing different types of immune cells were selected: CD45 antigen (PTPRC) is a receptor type protein tyrosine phosphatase necessary in the regulation of signal transduction in T-and B-cells. Therefore, CD45 is a suitable candidate to represent the collectivity of immune cells in the tissue sample or tertiary lymphatic inclusions. We then further characterized the immune cell compartment according to CD2, CD8, FOXp3 and CD20 expression. Infiltration of these cells into chronic pancreatitis (CP) and PDAC has been shown [31] . CD2 is a surface antigen expressed on all peripheral blood T-cells [32e34]; CD8 antigen is found in cancer patients on cytotoxic T-cells, mediating responses against cancer antigens [35] . Forkhead box protein 3 (FOXp3) serves as marker for regulatory T-cells [36e38]. CD20 is a marker for B-cells [39, 40] .
Analysis of specimens by quantitative reverse transcription (qRT)-PCR
Frozen pancreatic tumor tissue (34 samples) from PDAC patients was randomly chosen from an existing Pancobank of about 10,000 pancreatic specimens. The gene expression (number of mRNA copies per 10 kCPB) of the potential marker genes was correlated with the area-percentage values of the different cellular compartments on the slices via Spearman correlation ( Table 2,  Supplementary Table S2; Supplementary Table S3) . Overall, there was good correlation between RNA-based and histological annotation. Eleven of the 13 marker genes analyzed correlated with the appropriate cell types. Only the stroma content did not fit to the expression of COL1A1 or SMACTA2.
Based on these results, the best five molecular markers were defined to as RNACellStrat panel and studied in more detail: PNLIPRP2 for normal acinar parenchyma; INS for islets; CK19 for ductal and PDAC epithelium; LEP for fat tissue; and CD45 for immune infiltrates. Visualization via a boxplot indicated the presence of outliers. Gene expression values of PNLIPRP2, LEP and CD45 were defined as outliers that were distinctly separable. The values of INS and CK19 were regarded as outliers if expression was missing (<5 mRNA copies). Four outliers were detected each for PNLIPRP2, INS, LEP and CD45, and two for CK19 (Fig. 1A) . Strong expression of PNLIPRP2, LEP and CD45 suggested a sizeable amount of either normal pancreatic parenchyma, fat or immune infiltrates in the tissue samples. The absence of insulin expression in four samples should reflect an absence of b-cells of islets; consequently, the pancreatic nature of these four tissue samples was not certain. Since CK19 should be usually expressed in ductal tumor cells, the two samples lacking CK19 expression were conspicuous as well, assuming that no tumor cells are included in the tumor sample. In total, 18 abnormal expression values were noted for 11 tissue samples.
We scrutinized histological data to elucidate why the 11 tissues had such distinct profiles (Fig. 1B) . The four samples with high expression of PNLIPRP2 contained 34%e78% of normal pancreatic parenchyma (Fig. 1C, I ). The high LEP levels coincided with 68%e 82% inclusions of peripancreatic fat (Fig. 1C, II) . The strong CD45 expression correlated with a large amount of desmoplastic stroma infiltrated by immune cells (Fig. 1C, III) . The two samples lacking CK19 expression were the same ones that exhibited high LEP expression. Three other samples also have extremely low CK19 level. Three of the four tissues, which showed no expression of INS, had already been defined as outliers because of their high fat content. The source of the fourth sample was confirmed histologically as being pancreatic (Fig. 1C, IV) . The lack of INS expression was actually due to the absence of normal tissue areas, because the sample consisted primarily of pancreatic tumor cells. We would like to point out that only this one tissue sample had a tumor cell percentage of over 90% and, paradoxically, did not show high CK19 expression. All other 33 samples obtained from tumor patients contained between 0% and 40% of ductal tumor cells embedded in desmoplastic stroma. We noted that the five samples with low stromal content (16 ± 1% area) but high SMACTA2 and COL1A1 values (15,272 ± 5421 and 5452 ± 2807 copies/10 kCPB) displayed high fat content (75 ± 3% area and LEP-expression of 2197 ± 851 copies/10 kCPB; In summary, RNACellStrat procedure reduced the number of comparable tissue samples suitable for diagnostic and/or prognostic correlations from 34 to 23; a reduction of 32%. The 11 conspicuous samples had a composition that made them inappropriate for a comparative study since they were highly contaminated with normal parenchyma, fat or stroma.
Independent microarray analysis
For testing the robustness and thus broad applicability of the RNACellStrat annotation, an independent analysis was performed on a different set of samples with a different expression profiling procedure. 32 pancreatic tissue samples were selected from the Pancobank; there were 24 samples from patients with ductal adenocarcinoma, 1 case of chronic pancreatitis, 2 patients with cystic adenoma, 1 sample of cystic adenocarcinoma, 1 healthy pancreas, as well as 3 endocrine pancreas tumors.
Total RNA was isolated and used for a genome-wide expression analysis utilizing a commercial microarray platform. As before, a pathologist examined the composition of the H&E-stained tissue sections. The histological data was then compared to the results of the mRNA expression analysis. The signal intensities obtained from 17 microarray probes representing 10 genes were studied (Table 3,  Supplementary Table S4; Supplementary Table S5 ). The results of six gene probes correlated significantly with the area percentages of corresponding cell types: expression of AMY2A and PNLIPRP2 correlated with amount of normal pancreatic parenchyma (R ¼ 0.670, 0.664); INS with the islets (R ¼ 0.568); CK19 and MSLN with ductal tumor cells (R ¼ 0.598, 0.579); and the signal at the LEP_2 probe exhibited good correlation (R ¼ 0.535) with the amount of fat in the tissue samples. Correlation of the signals at the microarray oligonucleotide probes CD45_3 and CD45_4 and the volume of inflammatory infiltrates in the H&E-stained tissue section was significant, but the correlation coefficient showed only a fair degree of relationship (R ¼ 0.349, 0.410). As in the PCRapproach, stromal marker molecules (SMACTA2, COL1A1, FN1) did not correlate with the visually assessed areas of that tissue type in the sample. Therefore, PNLIPRP2, INS, CK19, and the LEP_2, and CD45_4 probes were selected to perform cellular annotation.
As before, the expression of the five marker genes in the pancreatic tissue samples was visualized via boxplots in a blinded manner, without presenting the sample annotations; an unblinded version is shown in Fig. 2A . There were 15 outlying values in 13 different samples. In twelve tissues, only one particular marker gene was expressed differently, while three markers were recognized as outliers in one tissue. Gene expression values of PNLIPRP2, LEP and CD45, which are out of range of dispersion, were defined as outliers. The values of INS and CK19 are regarded as outlier if expression is missing (<0.2 AU). Specifically, seven samples showed high PNLIPRP2 and three samples high LEP expression. One sample was conspicuous due to high LEP, extremely high CD45 and missing INS expression. Another two tissues did also not express INS. For these candidates, the tissue origin had to be further clarified. Actually, all outlier samples showed only minimal CK19 expression. The tissue with the lowest CK19 value (¼0.58) also had the highest LEP expression (¼3.18).
Upon un-blinding the diagnoses, it became apparent that most 'normal' pancreas parenchyma was observed in the healthy donor tissue. The highest CK19 expression was observed in the samples The five tumor samples that exhibited high PNLIPRP2 expression had areas of normal pancreas parenchyma that varied from 0% to 78%. The four LEP-expressing samples represented tissues containing a high amount of fat (34 %e71%). Histological staining of the one PDAC sample with the three remarkable results (high LEP, high CD45, no INS) revealed inclusions of fat and peripancreatic lymph node (Fig. 2C, I ). Histological validation of the H&E-stained sections of the remaining two PDAC tissue samples without INS expression elucidated that one sample was normal colon tissue (Fig. 2C, II) . In the other specimen, the pancreatic tumor type (desmoplastic areas and tumor cells) was confirmed and the sample was not excluded (Fig. 2C, III) .
In summary, RNACellStrat procedure reduced the number of tissue specimens from 32 to 21, a decrease of 34%. Utilizing the five markers, it was possible to eliminate samples that were rich in fat or normal pancreatic parenchyma and to identify non-PDAC entities and tissues from non-pancreatic origin such as lymph node or colon.
Influence of sample composition on prognosis
In order to prove the importance of performing the RNACellStrat procedure before evaluating prognostic or diagnostic markers and to show the applicability of the established procedure, a markerbased (S100A2) survival time analysis and signature-based PDAC sybtypes identification (with PDAssigner) was performed on an independent set of Pancobank samples, with and without intraanalytic RNACellStrat annotation. Microarray expression data of 98 PDAC patients were used for this analysis. The expression values observed for the five RNACellStrat marker genes were considered for stratification.
It had been shown that patients with low S100 calcium binding protein A2 (S100A2) expression in tumors had a better survival rate [41, 42] . In order to confirm prognostic relevance of S100A2 in our cohort, we assigned patients into two groups, S100A2 high and S100A2 low (mean value as cut-off), and performed a standard
KaplaneMeier survival analysis with a subsequent Log-rank test. Without RNACellStrat, 26 patients were allocated to the group with high S100A2 expression, and 72 to the group with low expression, based on the mean expression of the gene (cut-off ¼ 0.859). The median survival of the former group was 13.2 months, that of the latter 22.2 months. The Log-rank test showed that there is no significant difference between the two groups (p-value ¼ 0.172). The hypothesis that low expression of the S100A2 gene is associated with increased survival could not be confirmed (Fig. 3A) . With RNACellStrat, 23 tissue samples were identified as outliers (23%). Those tissue samples were excluded from the survival analysis ( Supplementary Fig. S1 ). The patient number was thus reduced from 98 to 75. Survival of 19 patients with high S100A2 expression (median survival time of 11.5 months) was compared to that of the other 56 patients (median survival time of 23.2 months). The mean S100A2 expression value of 0.893 served as the cut-off to divide the Fig. 3 . Influence of tissue cell composition on the prognostic value of the marker molecule S100A2. (a) From a total of 98 randomly selected patients, 26 patients were allocated in the group of high S100A2 expression (median survival 13.2 months) and 72 in the group with low expression (median survival 22.2 months). The result of a Log-rank test without prior RNACellStrat stratification according to cell composition showed no significant difference between the two groups. (b) After the RNACellStrat was performed, 28 samples were removed from the analysis. Of the remaining patients, 19 with high S100A2 expression (median survival 11.5 months) were compared to 56 patients with low expression (median survival time 23.2 months). A log-rank test showed a significant difference between the two groups (p-value ¼ 0.011).
patient into two groups. The result was in clear contrast to that of the first calculation about a correlation of survival and S100A2 expression. The log-rank test showed a highly significant difference between the two groups (p-value ¼ 0.011; Fig. 3B ), demonstrating the impact of the RNACellStrat process on prognostic significance. Collisson et al. developed a 62-gene signature, designated PDAssigner, capable of prognosis-relevant discrimination of the three PDAC subtypes: classical, quasimesenchymal and exocrinelike [43] . Cluster analysis of our microarray data sets showed that this identification by PDAC transcriptional phenotype could be achieved only with (n ¼ 75 patients) but not without (n ¼ 98 patients) RNACellStrat clearance (Heat maps generated using Chipster software [13] are given in Supplementary Fig. S2 ).
Discussion
Human tissue samples are an essential resource for oncological research. The prevalent sources of such material are biobanks. These facilities strive to provide well-annotated material of high quality, meeting ISO standards requiring an extensive quality control management [44e46]; but not each analyzed tissue sample is derived from an accredited biobank. At the same time, the need of effective networking in multi-centric and multi-national projects is growing with the intention of collecting a sufficiently large number of cases of different origin to assess the usefulness of a marker or drug [46, 47] . To such ends, a rigorous quality assessment of tissue samples is prerequisite.
Translational research requires tissue samples that represent a tumor as a whole and are annotated to a high level of accuracy. Often, this is not true for research material that is left over from standard diagnostics. It is therefore essential to define a tissue sample's quality very precisely before utilizing it for scientifically motivated molecular analyses and drawing any conclusions from their results. A precise determination of the abundance of different cell-types in tumor tissue is crucial to assuring comparability of samples, in particular for multicentric studies or for retrospective analyses that are based on data from public databases.
The established pathological method of tissue stratification is the macroscopic evaluation, followed by the evaluation of H&E-stained slices to define the diagnosis. It is essential to know if the resection margins are tumor-free and lymph-nodes are affected, which can be ascertained by the pathological examination. For molecular research, however, the precise amount of the different tissue types is of enormous interest. In the routine, tissue stratification is done with representative tissue slides to fulfill the diagnostic requirements, but the tissues are not necessarily prepared to perform molecular analyses. To save biochemical standards in molecular analysis, an additional approach for quantifying different tissue types, the imprint cytology, was created. It has been shown that this method is effective in eliminating samples with significant necrosis, but not in evaluating the quantity of tumor cells [48] .
In our study, we introduced an RNA-based procedure for a quantification of the cell composition of pancreatic tissue samples for molecular analyses, employing either qRT-PCR or microarray data. In 2010, Shen-Orr and colleagues already reported that differential gene expression patterns of diverse cell types correlate with relative cell-type frequencies in rat brain, liver and lung [49] . In a previous study [7] , we demonstrated that PNLIPRP2 gene expression allows to predict the percentage of normal pancreatic parenchyma found in pancreatic tumor samples. This prompted us to create a procedure for the molecular annotation of a tissue cellular composition, based on mRNA-expression profiles of a set of cell-type marker genes (RNACellStrat). This approach is advantageous in that it can be used as an internal control as long as the mRNA-profiles of the five marker genes are part of the relevant studies. Also, an internal validation of tissues can be performed, to guarantee the molecular based tissue composition, which is particularly important for retrospective or data depositories-based studies.
To maximize the number of experiments that can be performed from single specimen and to avoid repeated freeze-thaw cycles, pancreatic biopsies used for research purposes are frequently subdivided into smaller tissue specimens, thus delivering different cell composition of the individual fragments randomly selected for molecular profiling. From in total 164 tissue samples that were randomly selected from our Pancobank of some 10,000 samples, 45 would have been excluded from comparative analyses, equivalent to about 27%. When taking into account only the PDAC-diagnosed cohorts from qRT-PCR and microarray analyses (in total 156 samples), 43 samples which equal 28% were eliminated. RNACellStrat allowed identification of the samples suitable for prognostic associations. Next to stratification according to cellular composition, the established method allowed the identification of samples where the amount of malignant cells is insufficient or contain a high amount of fat or acinar cells, or even other adjacent organs such as colon or lymph nodes. By using only five marker genes, we managed to stratify tumor tissues according to their cellular composition. In consequence, 32% and 21% of the samples were eliminated from qRT-PCR and microarray analyses, respectively. Also, we demonstrated the applicability and importance of the method for improving prognostic accuracy through an exemplary survival analysis of PDAC patients. Usually, a significant reduction of the sample number in a study, here by 23%, leads to worsening of its statistical power. In this case, however, the reduction led to an increase in significance because the suitability of the remaining samples for prognostic correlations was proven by RNACellStrat yielding probes of a comparable composition. Moreover, RNACellStrat precluded wrong prognoses for the patients with excluded samples. Finally, our data suggested that an interpretation of stroma-related molecular findings should be considered prior to exclusion of LEP high (fat) samples because mesenchymal cells in adipose tissues might express similar sets of marker molecules.
In conclusion, the results show that the determination of tumor tissue composition is crucial for the interpretation of expression profiles and other molecular data and influences their prognostic value significantly. The process represents a complement or alternative procedure to pre-analytic histological evaluation. In this way, the procedure increases reliability of the results of biomedical studies and improves prognostic accuracy while reducing the probability of findings' misinterpretation. While the process is optimized for a cellular annotation of pancreatic tumor tissues, the strategy may be transferred and applicable to other diseases and tissue types, displaying a tool to strengthen the molecular tissue analysis.
